Nesacaine
NDC Package 0186-0992-66

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Nesacaine is a . Marketed by Astrazeneca Pharmaceuticals Lp, this product is identified by NDC 0186-0992 and is authorized under FDA application NDA009435.

Identification & Billing

NDC Package Code
0186-0992-66
Package Description
20 mL in 1 VIAL, SINGLE-DOSE
Product Code
0186-0992
11-Digit Billing Format
00186099266
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
Units Per Package
20 ML

Clinical Specifications

Proprietary Name
Nesacaine
Dosage Form
-

Regulatory & Marketing

Labeler Name
Astrazeneca Pharmaceuticals Lp
FDA Application #
NDA009435
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
10-01-1996
End Marketing Date
03-31-2010
Listing Expiration
03-31-2010
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0186-0992-66 identifies a specific commercial package of 20 ml in 1 vial, single-dose of Nesacaine, labeled by Astrazeneca Pharmaceuticals Lp. This product is billed per "ML" milliliter and contains an estimated amount of 20 billable units per package. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Astrazeneca Pharmaceuticals Lp on October 01, 1996. The current certification is valid through March 31, 2010.

How is this Astrazeneca Pharmaceuticals Lp product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00186099266. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 20 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0186-0992-66
11-Digit CMS (5-4-2)
00186-0992-66

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.